Jpmorgan Chase & CO Sc Pharmaceuticals Inc. Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SCPH
# of Institutions
79Shares Held
27.8MCall Options Held
39.2KPut Options Held
2.6K-
Orbimed Advisors LLC San Diego, CA5.56MShares$22.4 Million0.58% of portfolio
-
Rubric Capital Management LP New York, NY3.53MShares$14.2 Million0.45% of portfolio
-
Aigh Capital Management LLC Baltimore, MD3.5MShares$14.1 Million5.52% of portfolio
-
King Luther Capital Management Corp Fort Worth, TX2.21MShares$8.89 Million0.04% of portfolio
-
Black Rock Inc. New York, NY1.77MShares$7.13 Million0.0% of portfolio
About scPharmaceuticals Inc.
- Ticker SCPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,402,100
- Market Cap $110M
- Description
- scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...